These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6573569)

  • 1. Therapy of secondary acute nonlymphocytic leukemia.
    Beltran G; Stuckey WJ
    N Engl J Med; 1983 May; 308(21):1295-6. PubMed ID: 6573569
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine.
    Kaplan HG; Appelbaum FR; Cheever MA; Greenberg PD; Wood T; Fefer A
    Cancer Treat Rep; 1982 Jun; 66(6):1397-8. PubMed ID: 7083242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daunorubicin versus aclarubicin in combination with cytarabine and thioguanine in elderly patients with acute nonlymphocytic leukemia, a preliminary report.
    Björkholm M; Killander A
    Eur J Haematol Suppl; 1987; 47():49-54. PubMed ID: 3471525
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of acute non-lymphocytic leukemia in Saitama Cancer Center.
    Sampi K; Sakurai M; Kaneko Y; Hattori M
    Anticancer Res; 1985; 5(3):293-6. PubMed ID: 4015043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies with anthracyclines in pediatric acute nonlymphocytic leukemia.
    Chard RL
    Cancer Treat Rep; 1981; 65 Suppl 4():77-81. PubMed ID: 6179617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with aclacinomycin in acute leukemia.
    Krc I; Myslivecek M; Mlcochová E
    Acta Univ Palacki Olomuc Fac Med; 1986; 113():141-7. PubMed ID: 2941978
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapeutic approach to acute myeloid leukemia in adults].
    Biron GL; Lapointe Y; Clément S; Maheu M; Laurin S; Gosselin BY
    Union Med Can; 1983 May; 112(5):412-4. PubMed ID: 6576502
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
    Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K
    Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved treatment of acute nonlymphocytic leukemia in a community hospital--The Marshfield Clinic/St Joseph's Hospital; experience 1974-1981.
    Conterato JP; Friedenberg WR; Mazza JJ; Gatlin P; Gehlsen JA; Schloesser LL
    Wis Med J; 1983 Dec; 82(12):17-21. PubMed ID: 6582689
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
    Wiernik PH
    Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors in response to anthracyclines.
    McCredie KB; Keating MJ; Bodey GP; Gehan EA; Smith T; Freireich EJ
    Cancer Treat Rep; 1981; 65 Suppl 4():83-6. PubMed ID: 6955014
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy of secondary acute nonlymphocytic leukemia with cytarabine.
    Preisler HD; Early AP; Raza A; Vlahides G; Marinello MJ; Stein AM; Browman G
    N Engl J Med; 1983 Jan; 308(1):21-3. PubMed ID: 6847919
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of progress in hematology in 1981 with special reference to leukocyte.
    Kimura K
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):1-10. PubMed ID: 7051724
    [No Abstract]   [Full Text] [Related]  

  • 18. High remission induction (traditional sino-western HOAP) regimen for acute nonlymphocytic leukemia.
    Chin Med J (Engl); 1980 Aug; 93(8):565-8. PubMed ID: 6772409
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs.
    Park CH; Wiernik PH; Morrison FS; Amare M; Van Sloten KV; Maloney TR
    Cancer Res; 1983 May; 43(5):2346-9. PubMed ID: 6572563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements.
    Preisler HD; Priore R; Azarnia N; Barcos M; Raza A; Rakowski I; Vogler R; Winton EL; Browman G; Goldberg J
    Br J Haematol; 1986 Aug; 63(4):625-36. PubMed ID: 3460626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.